SCHEMBL3874333

SCHEMBL3874333

CSc1cc(N)c2oc3ccccc3c2c1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.41
KDM4E B2RXH2 9/20 0.38
ALDH1A1 P00352 9/20 0.38
HPGD P15428 7/20 0.38
GAA P10253 7/20 0.38
MAPT P10636 5/20 0.38
RAB9A P51151 3/20 0.38
HSD17B10 Q99714 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 2/20 0.38
LIMK1 P53667 1/20 0.36
MAOA P21397 2/20 0.35
GLA P06280 1/20 0.35
AHR P35869 1/20 0.35
LMNA P02545 3/20 0.35
USP2 O75604 1/20 0.35
MAPK1 P28482 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3880375 0.88 NQO1 (0.41) NQO1KDM4EALDH1A1HPGDGAA
SCHEMBL3882623 0.81 NQO1 (0.43) NQO1KDM4EALDH1A1HPGDGAA
SCHEMBL3881093 0.78 NQO1 (0.43) NQO1KDM4EALDH1A1HPGDGAA
SCHEMBL3875231 0.77 NQO1 (0.44) NQO1KDM4EALDH1A1HPGDGAA
SCHEMBL3879176 0.77 MAOA (0.50) KDM4EALDH1A1HPGDMAPTRAB9A
SCHEMBL29362427 0.73 NQO1 (0.46) NQO1KDM4EALDH1A1HPGDGAA
SCHEMBL17584775 0.73 NQO1 (0.46) NQO1KDM4EALDH1A1HPGDGAA
SCHEMBL3874492 0.73 PKM (0.54) NQO1KDM4EALDH1A1HPGDGAA
SCHEMBL27252204 0.73 L3MBTL1 (0.38) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL31442257 0.72 AHR (0.49) NQO1KDM4EALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof GLENN ROBERT W JR 2008-05-01 US claimed
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-06 US claimed
US-7491245-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2009-02-17 US disclosed
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof GLENN ROBERT W JR 2008-05-01 US disclosed
US-7331997-B2 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof THE PROCTER & GAMBLE COMPANY (US) 2008-02-19 US disclosed
EP-1735059-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF The Procter and Gamble Company (US) 2006-12-27 EP disclosed
WO-2005099656-A2 KERATIN DYEING COMPOUNDS, KERATIN DYEING COMPOSITIONS CONTAINING THEM, AND USE THEREOF THE PROCTER & GAMBLE COMPANY (US) 2005-10-27 WO disclosed
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof PROCTER & GAMBLE COMPANY, THE 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050217038-A1 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof KRT18, CKMT1A; CKMT1B, TUBB6 NQO1 222/4885KDM4E 1549/4885ALDH1A1 660/4885
US-20080098535-A1 Keratin Dyeing Compounds, Keratin Dyeing Compositions Containing Them, And Use Thereof KRT18, CKMT1A; CKMT1B, TUBB6 NQO1 222/4885KDM4E 1549/4885ALDH1A1 660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.